BACKGROUND:Master Services Agreement • April 4th, 2008 • Xanodyne Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledApril 4th, 2008 Company Industry Jurisdiction
RECITALSTransfer and Assumption Agreement • April 4th, 2008 • Xanodyne Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledApril 4th, 2008 Company Industry Jurisdiction
EXHIBIT 10.13 Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. MANUFACTURING AGREEMENT This MANUFACTURING AGREEMENT (this "AGREEMENT") dated as of the first day of January,...Quality Agreement • April 4th, 2008 • Xanodyne Pharmaceuticals Inc • Pharmaceutical preparations • Ohio
Contract Type FiledApril 4th, 2008 Company Industry Jurisdiction
EMPLOYMENT AGREEMENTEmployment Agreement • April 4th, 2008 • Xanodyne Pharmaceuticals Inc • Pharmaceutical preparations • Kentucky
Contract Type FiledApril 4th, 2008 Company Industry JurisdictionThe following numbered paragraphs set forth the terms and conditions that will apply if you timely sign and return this letter agreement and do not revoke it in writing within the seven (7) day period.
BACKGROUNDLicensing Agreement • April 4th, 2008 • Xanodyne Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledApril 4th, 2008 Company Industry Jurisdiction
BACKGROUNDCommercial Manufacturing Agreement • April 4th, 2008 • Xanodyne Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledApril 4th, 2008 Company Industry Jurisdiction
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. McKesson Corporation Core Distribution AgreementCore Distribution Agreement • April 4th, 2008 • Xanodyne Pharmaceuticals Inc • Pharmaceutical preparations • California
Contract Type FiledApril 4th, 2008 Company Industry JurisdictionThis Core Distribution Agreement (“Agreement”) is entered into as of November 1 , 2005 (the “Effective Date”) between McKesson Corporation (“McKesson”), a pharmaceutical distributor, and Xanodyne Pharmaceuticals, Inc. (“Manufacturer”), a pharmaceutical company.
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. Cardinal Health Developing Suppliers Program Distribution Services AgreementDistribution Services Agreement • April 4th, 2008 • Xanodyne Pharmaceuticals Inc • Pharmaceutical preparations • Ohio
Contract Type FiledApril 4th, 2008 Company Industry JurisdictionThis Agreement (“Agreement”) is entered into as of October 1, 2004 (the “Effective Date”) by and between Xanodyne Pharmaceuticals Inc. (“Supplier”), a Kentucky corporation with its principal place of business located at 7300 Turfway Rd. Suite 300, Florence, KY 41042, and Cardinal Health* (“Cardinal Health”) with its principal place of business located at 7000 Cardinal Place, Dublin, Ohio 43017.
EMPLOYMENT AGREEMENTEmployment Agreement • April 4th, 2008 • Xanodyne Pharmaceuticals Inc • Pharmaceutical preparations • Kentucky
Contract Type FiledApril 4th, 2008 Company Industry JurisdictionTHIS EMPLOYMENT AGREEMENT (this “Agreement”) is made as of December 19, 2007, by and between Xanodyne Pharmaceuticals, Inc., a Delaware corporation with a principal place of business at One Riverfront Place, Newport, Kentucky (the “Company”), and Greg Flexter, an individual (the “Employee”).